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    Background.         Data comparing returned travelers and immigrants/refugees managed in a hospital setting is lacking. 
  Methods.         We prospectively collected data on 1,106 patients with an illness likely acquired overseas who presented to 
two hospital-based Australian infectious diseases units over a 6-year period. 
  Results.         Eighty-three percent of patients were travelers and 17% immigrants/refugees. In travelers, malaria (19%), 
gastroenteritis/diarrhea (15%), and upper respiratory tract infection (URTI)     (7%) were the most common diagnoses. 
When compared with immigrants/refugees, travelers were signiﬁ  cantly more likely to be diagnosed with gastroen-
teritis/diarrhea [odds ratio (OR) 8], malaria (OR 7), pneumonia (OR 6), URTI (OR 3), skin infection, dengue fever, 
typhoid/paratyphoid fever, inﬂ  uenza, and rickettsial disease. They were signiﬁ  cantly less likely to be diagnosed with 
leprosy (OR 0.03), chronic hepatitis (OR 0.04), tuberculosis (OR 0.05), schistosomiasis (OR 0.3), and helminthic 
infection (OR 0.3). In addition, travelers were more likely to present within 1 month of entry into Australia (OR 96), 
and have fever (OR 8), skin (OR 6), gastrointestinal (OR 5), or neurological symptoms (OR 5) but were less likely to 
be asymptomatic (OR 0.1) or have anaemia (OR 0.4) or eosinophilia (OR 0.3). Diseases in travelers were more likely 
to have been acquired via a vector (OR 13) or food and water (OR 4), and less likely to have been acquired via the 
respiratory (OR 0.2) or skin (OR 0.6) routes. We also found that travel destination and classiﬁ  cation of traveler can 
signiﬁ  cantly inﬂ  uence the likelihood of a speciﬁ  c diagnosis in travelers. Six percent of travelers developed a poten-
tially vaccine-preventable disease, with failure to vaccinate occurring in 31% of these cases in the pretravel medical 
consultation. 
  Conclusions.         There are important differences in the spectrum of illness, clinical features, and mode of disease trans-
mission between returned travelers and immigrants/refugees presenting to hospital-based Australian infectious dis-
eases units with an illness acquired overseas.       
  I
n Australia, health care providers are being 
  increasingly faced with patients who have re-
cently traveled overseas or immigrated. In 2002, 3.5 
million Australian residents traveled overseas,    1     4.8 
million travelers visited Australia   1     and 110,000 per-
manent immigrants arrived in Australia.    2     These 
  patients often develop illnesses acquired overseas, 
many of which require hospital care, yet the 
illnesses may be uncommon in the country in which 
they are managed. If not recognized and managed 
correctly, these illnesses can have signiﬁ  cant 
  morbidity and mortality. Thus, to provide accurate 
diagnosis and high quality management, health care 
providers need to be aware of the common diag-
noses, spectrum of diagnoses, travel characteristics, 
and clinical patterns of the patient population that 
present in their region having crossed international 
borders. 
      Paper presented at the 9th Conference of the Interna-
tional Society of Travel Medicine, Lisbon, May 2005.  
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  Despite this, few prospective studies have been 
performed on returned travelers managed in a hos-
pital setting with an illness acquired overseas, and 
these have focused on those with fever,    3  –  5     inpa-
tients,    6     or children.   7,8     To our knowledge, none have 
been performed examining the whole spectrum of 
illness in adult returned travelers in this setting, and 
thus important clinical and epidemiological infor-
mation for this patient population is lacking. 
  In addition, although immigrants from develop-
ing to developed countries have been reported to 
have high rates of infectious diseases acquired in 
their country of origin, most of these studies have 
been performed in the nonhospital setting and fo-
cused on speciﬁ  c health problems   9  –  11     or immigrants 
from speciﬁ  c regions.    12,13     
  Due to likely differences in such things as the type 
and duration of exposure to endemic infections, ac-
cess to immunization and disease prophylaxis, prior 
medical screening, and health-seeking behaviors, 
the spectrum of disease and clinical characteristics 
in immigrants/refugees are likely to differ from 
those in returned travelers. However, as far as we 
are aware, no previous studies have compared the 
spectrum of illness in returned travelers with that in 
immigrants/refugees managed in a hospital setting. 
  We aimed to prospectively study travelers and im-
migrants/refugees with an illness acquired overseas 
presenting to two hospital-based Australian special-
ist infectious diseases units over a 6-year period. We 
planned to describe and compare the demographics, 
common diagnoses, clinical features, and mode of 
disease transmission for these two patient groups. 
    Methods 
  Study patients were managed at the Victorian Infec-
tious Diseases Service (VIDS) at the Royal Melbourne 
Hospital (RMH), a 400-bed tertiary referral centre, or 
the Geelong Infectious Diseases Service (GIDS) at the 
Geelong hospital (GH), a 400 bed regional hospital. 
Data was collected prospectively over a 74-month 
period between July 1, 1998 and September 30, 2004 
at the RMH, and a 37-month period between 
September 1, 2001 and September 30, 2004 at the 
GH. Retrospective data was collected by review of 
medical records for 18 months (January 1, 1997 to 
June 30, 1998) at RMH. To be included, patients had 
to be judged to have acquired their illness outside 
Australia by the treating infectious diseases specialists. 
  Data collected included patient demographics 
and classiﬁ   cation, travel dates and destination, 
previous travel, date of presentation, presenting 
symptoms, pretravel vaccinations and malarial 
prophylaxis, examination ﬁ  ndings, investigation 
results, diagnosis, treatment, and outcome. 
  The following deﬁ  nitions were used: 
    Patient Classiﬁ  cation   
    a.     Traveler included the following      
    1.     Australian traveler: An Australian resident who 
has traveled across international boundaries.  
    2.     An Expatriate: An Australian resident living 
outside Australia in a single country for the 
purpose of work or education for a period 
  longer than 1 month.  
    3.     A visitor: A non-Australian resident traveling 
to Australia for reasons other than immigra-
tion or as a refugee.  
    b.       Immigrant/refugee: A person living in Australia 
whose most recent travel was to Australia as a 
refugee or for immigration purposes.      
    Regions 
  Countries were assigned the following broad 
  regional classiﬁ  cation if they were situated within 
the following areas:  
    1.  Asia: South East Asia and the Indian subcontinent.  
    2   Africa: The African continent.  
    3.   The Paciﬁ  c: In the Paciﬁ  c Ocean east of  Australia, 
including New Zealand and Papua New Guinea, 
but excluding Hawaii.  
    4.  Latin America: Central and South America.  
    5. Middle-East   
    6. North  America   
    7. Europe       
    Diagnosis 
  Diagnoses were established by (1) demonstration of a 
microorganism in a clinically relevant specimen or (2) 
seroconversion to an infectious agent considered to be 
acquired overseas and responsible for the patient  ’  s 
clinical illness. If a speciﬁ  c causative organism could 
not be identiﬁ  ed, a clinical diagnosis was assigned. 
Presumptive diagnoses were based on epidemiologi-
cal and clinical features, supporting laboratory inves-
tigations and response to speciﬁ  c  treatment.  Diagnoses 
were assigned by the authors of this study or by the 
specialist infectious diseases physicians of VIDS. 
  For analysis, patients classiﬁ  ed as travelers were 
compared to those classiﬁ  ed as immigrants/refugees. 
  Information was entered into an Access database 
(Microsoft) and analyzed using Epi-Info 6 (Centers 
for Disease Control, Atlanta). Statistical signiﬁ  -
cance was determined using the       2   test for 2 × 2 
  tables for each of the categorical values.    147
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    Results 
    Demographics and Travel Characteristics 
  A total of 1,106 patients of which 626 (57%) were 
male were included in the study. The mean age was 
34.2 years (range of 4  –  98 years). Only one patient 
was younger than 14 years of age (4 years). Fifty-
four percent were managed as outpatients. 
  A total of 917 (83%) patients were classiﬁ  ed as 
travelers, and 189 (17%) as immigrants/refugee. Of 
the travelers, 653 (71%) were Australian travelers, 
152 (17%) were foreign visitors, and 112 (12%) 
were living as expatriates. 
  For immigrants/refugees, 82 (43%) were born in 
Africa, 80 (42%) in Asia, 12 (6%) in Europe, 7 (4%) 
in Oceania, 6 (3%) in the Middle-East, and 2 (1%) 
in Latin America. 
  For travelers, 515 (56%) had traveled to Asia, 134 
(15%) to Africa, 128 (14%) to the Paciﬁ  c, 76 (8%) to 
Europe, 50 (6%) to Latin America, 41 (4%) to North 
America, and 37 (4%) to the Middle-East. Sixty four   
(7%) had traveled to more than one of these regions, 
and 810 (88%) had traveled to a developing country. 
  The duration of travel for those classiﬁ  ed as trav-
elers could be determined in 871 (95%) cases: 528 
(61%) had traveled for <30 days, 254 (29%) for 1 to 
6 months, and 89 (10%) for >6 months.  
    Diagnosis 
  There were 1,220 separate diagnoses in the 1,106 
patients. Malaria, gastroenteritis/diarrhea, and 
  upper respiratory tract infection (URTI) were the 
most common diagnoses in all travelers (Table     1) 
and in febrile travelers (Table     3). In immigrants/
refugees tuberculosis, schistosomiasis, helminthic 
infection, chronic hepatitis, and leprosy were the 
most common diagnoses (             Table    2  ).   
    Comparison Between Travelers and Immigrants/
Refugees (Table    4) 
    Demographics 
  There was no signiﬁ  cant difference in gender or age.  
    Diagnoses 
  Travelers were eight, seven, and six times more likely 
to be diagnosed with gastroenteritis, malaria, or 
pneumonia, respectively. Other diagnoses found 
signiﬁ  cantly more often in travelers were URTI, skin 
infection, dengue fever, typhoid/paratyphoid fever, 
inﬂ  uenza, rickettsial disease, and illness unknown. 
  Compared to travelers, leprosy (31 times), 
chronic hepatitis (30 times), tuberculosis (21 times), 
schistosomiasis (4 times), and helminthic infection 
(3 times) were signiﬁ  cantly more likely in immi-
grants/refugees.   
    Clinical and Laboratory 
  Compared to immigrants/refugees, travelers were 
signiﬁ   cantly more likely to present with fever 
(8 times), skin (6 times), gastrointestinal (5 times), 
or neurological symptoms (5 times). However, they 
were less likely to have anemia or eosinophilia.  
    Time to Presentation From Return to, or Entry 
into, Australia 
  Travelers were 96 times more likely to present 
within 1 month of return, while immigrants/refu-
gees were 93 times more likely to present more than 
6 months after their entry into Australia.  
    Mode of Transmission 
  The mode of transmission was determined for 761 
diagnoses in travelers and 169 diagnoses in immi-
grants/refugees. Vector-borne (13 times) and food- 
and waterborne diseases (4 times) were signiﬁ  cantly 
more likely in travelers, but respiratory (5 times) 
and skin diseases (2 times) were signiﬁ  cantly more 
likely in immigrants/refugees.    
    Comparison of  Travel Destination and Patient 
Classiﬁ  cation for the Common Diagnoses in Travelers 
  For the most common diagnoses found in travelers, 
travel characteristics involving  travel destination   and 
  classiﬁ  cation of traveler   for a speciﬁ  c diagnosis were 
analyzed against travelers without that diagnosis to 
look for signiﬁ  cant associations between the diag-
nosis and one of these speciﬁ  c patient characteris-
tics (Table     5). For example, travel to Asia was ﬁ  ve 
times more likely for travelers diagnosed with den-
gue fever than those without that diagnosis, three 
times more likely for those with typhoid and paraty-
phoid fever, and eight times more likely for those 
with tuberculosis. In addition, those diagnosed with 
pneumonia were 11 times more likely to be classi-
ﬁ  ed as Australian travelers than those without a di-
agnosis of pneumonia, and malaria was four times 
more likely in those classiﬁ  ed as expatriate. Further 
associations can be seen in              Table    5  .   
    Pretravel Advice/Vaccination for Travelers 
  Pretravel vaccinations in our patients included hep-
atitis A (331 patients, 36%), typhoid fever (322 pa-
tients, 35%), hepatitis B (213 patients, 23%), 
diphtheria/tetanus (177 patients, 19%), polio (160 
patients, 17%), yellow fever (96 patients, 11%), me-
ningococcal disease (93 patients, 10%), rabies (47 
patients, 5%), Measles Mumps Rubella (MMR)    (36 
patients, 4%), tuberculosis (Bacille Calmette -Guérin 
[BCG]; 28 patients, 3%), Japanese encephalitis (28 
patients, 3%), cholera (22 patients, 2%), inﬂ  uenza 148
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(3 patients, <1%) and   Hemophilus inﬂ  uenzae   infec-
tion (2 patients, <1%). 
  Compared to other diagnoses in travelers, those 
who were not known to be vaccinated against 
    Salmonella typhi   (19/595) were 11 times more likely 
to be diagnosed with typhoid fever than those who 
had been vaccinated (1/322) [odds ratio (OR) 11, 
95% CI 2 –  213,  p   < 0.01].  
    There were no vaccine failures for those diag-
nosed with hepatitis A. However, for 3 of 9 cases of 
hepatitis A who had sought pretravel advice, a pre-
ventative vaccine was not administered. Ten of 23 
(43%) patients diagnosed with inﬂ  uenza had sought 
pretravel medical advice but had not been vacci-
nated against inﬂ  uenza. Only 1 of 36 (3%) patients 
who presented for rabies post-exposure prophylaxis 
(PEP)     had received pretravel rabies vaccination. 
Thirteen (36%) of these patients had traveled <1 
month.
Mortality Rate 
  The mortality rate was 0.2% (2 of 1,106). Both 
deaths were due to bacterial pneumonia, one in an 
Australian traveler and one in a visitor.    
    Discussion 
  We have prospectively described and compared the 
common causes and range of diagnoses for illness 
acquired overseas in a large number of adult travel-
ers (917) and immigrants/refugees (189) seen in two 
hospital-based Australian infectious diseases units 
over a 6-year period (                         Tables    1, 2, and 3 ). 
  Several important differences in the likelihood 
of infections were found when returned travelers 
were compared to immigrants/refugees (              Table     4  ). 
For immigrants and refugees, these differences 
likely reﬂ  ect a combination of factors, which may 
include a higher intensity and greater duration of 
exposure to endemic infections, lack of vaccination 
and prophylactic medication, medical screening 
          Table     1         Most common diagnoses in travelers 
(  n     =   917)         
      Diagnosis  *     Number of cases     †        % of travelers        
  Malaria   174   19     
  Gastroenteritis/diarrhea   136   15     
  URTI   61   7     
  Illness unknown    53   5     
  Dengue fever    50   5     
  Skin infection    50   5     
  Tuberculosis   42   5     
  Rabies PEP    36   4     
  Schistosomiasis   35   4     
  Bite, animal    33   4     
  Helminth infection    30   3     
  Pneumonia   29   3     
  Typhoid/paratyphoid fever    28   3     
  Viral syndrome    25   3     
  Inﬂ  uenza A/B    23   3     
    Entamoeba histolytica     20   2     
  Rickettsial disease    18   2     
  Urinary tract infection    17   2     
  Acute hepatitis    17   2     
  CNS infection    9   1     
  Eosinophilia   7   1     
  Herpes virus    6   1     
  Deep abscess    6   1     
  HIV   4   <1     
  STI   4   <1     
  Bacterial sepsis    4   <1     
  Lyme disease    4   <1     
  Acute arthritis    4   <1     
  Chronic hepatitis    3   <1     
  Leprosy   2   <1     
  Leptospirosis   2   <1     
  Other   84   11     
        URTI  =   upper respiratory tract infection. 
              *  Note for speciﬁ  c diagnoses (number of cases in brackets): 
   1.      Upper respiratory tract infection   included nonspeciﬁ  c URTI (35), 
streptococcal pharyngitis (9), bronchitis (7), acute sinusitis (5), ton-
sillitis (4), unspeciﬁ  ed pharyngitis (4), and pertussis (1). 
   2.      Tuberculosis   included tuberculous infection (77) and tuberculous dis-
ease (59). Sites of disease were extrapulmonary (31), pulmonary (22), 
and disseminated (6). 
   3.      Gastroenteritis/diarrhea   included gastroenteritis (74), chronic diar-
rhea (32), acute diarrhea (13), gastritis (8), bacterial diarrhea (7), par-
asitic diarrhea (5), and tropical sprue (1). 
   4.    S  kin infection   included cutaneous larva migrans (18), cellulitis (10), 
nonspeciﬁ  c skin infection (6), insect/marine bite (5), cutaneous fun-
gus (3), cutaneous leishmaniasis (2), impetigo (2), infected bite (2), 
erysipelas (1), and sporotrichosis (1). 
   5.      Helminthic   cases comprised Strongyloides (16), Taeniae (7), hook-
worm (5), Echinococcus (4), onchocerciasis (3), gnathostomiasis (2), 
Ascaris (2), Fasciola (1), Clonorchis (1), and unspeciﬁ  ed (7). 
   6.      HIV   included cases of AIDS (4), acute seroconversion (2), and 
asymptomatic infection (1). 
   7.      Urinary tract infection   included acute urinary tract infection (9), 
pyelonephritis (8), and epididymitis (1). 
   8.      CNS infection   included acute encephalitis (4), viral meningitis (4) and 
bacterial meningitis (1). 
   9.      Acute hepatitis   included hepatitis A (10), hepatitis E (5), and nonspeci-
ﬁ  ed cases (2). 
  10.    Chronic hepatitis   included hepatitis B (13) and hepatitis C (7). 
  11.  STI   included gonorrhoea (2) and syphilis (2). 
  12.    Herpes virus   included Epstein-Barr virus (4), Herpes simplex virus 
(2), and Cytomegalovirus (1). 
  13.      Bacterial sepsis   included that caused by  Neisseria meningitidis   (1),  Strep-
tococcus pneumoniae   (1),   Hemophilus parainﬂ  uenzae   (1),   Escherichia coli   
(1), and an undeﬁ  ned Gram-negative bacillus (1). 
  14.    Pneumonia   included 2 cases due to Mycobacterium kansassii and 1 
due to Legionella pneumophila. 
  15.    Typhoid/paratyphoid   fever included   Salmonella typhi   (20) and   Salmo-
nella paratyphi   (8) infections. 
  16.    Other   included screening (23), noninfectious medical condition (19), 
rash (17), fatigue (13), drug adverse reaction (6), trauma (4), allergic 
reaction (2), psychosis (2), endocarditis (1), otitis externa (1), dental 
(1), tropical pulmonary eosinophilia (1), myiasis (1), measles (1), 
toxoplasmosis (1), viral syndrome (1), illness unknown (1), and 
lymphadenopathy (1).                  
†    Travelers may have more than one diagnosis.              149
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prior to arrival into Australia, and reduced access to 
health care services upon arrival. 
  Signiﬁ   cant differences, regarding the time to 
presentation and the clinical features, were also 
found when travelers were compared to immi-
grants/refugees ( Table    4  ). These differences may be 
explained by the fact that they might have had difﬁ  -
culties accessing hospital care, that they accessed 
other health care sources for more acute conditions 
upon arrival, that most of the conditions were 
chronic and took time to become clinically evident, 
or that as they were more likely to be asymptomatic, 
they required targeted screening by clinicians expe-
rienced in immigrant/refugee health for diagnosis. 
In addition, when comparing travelers relative to 
immigrants/refugees, it was found that in travelers, 
more focus should be placed on considering diseases 
that are vector- or food- and waterborne, as they are 
more likely, and less focus on those acquired via 
the respiratory or skin routes, which are less likely 
(  Table     4  ). We feel all the above comparisons reveal 
important differences that can aid the clinician 
in the assessment and management of illness in 
returned travelers or immigrants/refugees. 
  Another hospital-based study on immigrants/
refugees also found high rates of tuberculosis, hel-
minthic infection, and chronic hepatitis.    11     How-
ever, conversely, they found high rates of ﬁ  lariasis 
(onchocerciasis and mansonella), which was due to 
the high proportion of patients seen from Western 
Africa (>55%), and malaria, which was probably re-
lated to their high proportion of immigrants from 
sub-Saharan Africa (77% vs 43%), and the high 
proportion (72%) of undocumented migrants who 
had likely not undergone prior medical screening. 
  We have previously described the common causes 
of fever in 232 returned travelers admitted to our in-
stitution.    3     In the present study, we have analyzed 624 
febrile returned travelers and found that the top 10 
most common diagnoses remained unchanged ex-
cept that   Hepatitis A   has been replaced by   viral syn-
drome  . This may represent a reduced incidence of 
hepatitis A over time in returned travelers due to bet-
ter coverage with pretravel hepatitis A vaccination. 
  Our study has also shown that travel to speciﬁ  c 
regions and the classiﬁ  cation type for the traveler 
can inﬂ  uence the likelihood of a traveler presenting 
with a speciﬁ  c diagnosis (  Table    5  ). For example, 
compared to those who have not, patients in our 
study who had traveled to Africa were nine times 
more likely to be diagnosed with schistosomiasis, 
ﬁ  ve times more likely with rickettsial disease, and 
twice as likely with malaria. However, they were 
signiﬁ  cantly less likely to be diagnosed with dengue 
fever or gastroenteritis/diarrhea. In addition, those 
classiﬁ  ed as visitors were signiﬁ  cantly more likely to 
present with tuberculosis or typhoid/paratyphoid 
fever, and less likely to present with schistosomiasis 
and an URTI compared to other travelers. 
  Similarly, although malaria should always be con-
sidered in returned travelers, in our patient popula-
tion, special attention should be paid to those who 
have traveled to Africa and the Paciﬁ  c or have trav-
eled as expatriates, as they had a signiﬁ  cantly higher 
likelihood of having malaria than other travelers. 
  Again, we believe these are important ﬁ  ndings, 
as it allows the treating clinician to use this informa-
tion regarding travel epidemiology and patient 
classiﬁ  cation to make informed judgments regard-
ing illness probability when assessing returned trav-
elers in their hospitals. 
          Table     2         Most common diagnoses in immigrants/
refugees (  n     =   189)         
      Diagnosis  *   
  Number of 
cases      †      
  % of immigrants/
refugees         
  Tuberculosis   94   50     
  Schistosomiasis   24   13     
  Helminth infection    18   10     
  Chronic hepatitis    17   9     
  Leprosy   12   6     
  Malaria   6   3     
  Gastroenteritis/diarrhea   4   2     
  URTI   4   2     
  HIV   3   2     
  Eosinophilia   3   2     
    Entamoeba histolytica     2   1     
  Other   17   9     
        URTI   =   upper respiratory tract infection.             
  *  See footnote to   Table    1.                       
†     Immigrants/refugees may have more than one diagnosis.               
          Table     3         Most common diagnoses in febrile travelers 
(  n     =   624)         
      Diagnosis   Number of cases *     %         
  Malaria   167   27     
  Gastroenteritis/diarrhea   75   12     
  URTI   51   8     
  Dengue fever    46   7     
  Unknown   45   7     
  Typhoid/paratyphoid fever    28   4     
  Pneumonia   25   4     
  Inﬂ  uenza A/B    23   4     
  Viral syndrome    23   4     
  Rickettsial disease    16   3     
  Urinary tract infection    16   3     
  Skin infection    10   2     
  Helminth infection    10   2     
  Hepatitis A    9   1     
            *  Travelers may have more than one diagnosis.               150
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  It is worth noting that rabies PEP accounted for 
the ninth most common diagnosis in returned trav-
elers; yet, only 5% of travelers had pretravel rabies 
vaccination. Pretravel vaccination avoids the need 
for the often difﬁ  cult to obtain, and potentially dan-
gerous, rabies immunoglobulin postexposure,   14     and 
also reduces the number of postexposure vaccina-
tions required, while giving some protection for 
unreported exposures or where postexposure pro-
phylaxis may be delayed. In Australia, pretravel ra-
bies vaccination is recommended for travelers to 
endemic countries for periods of >1 month or when 
undergoing high-risk activities.    15,16     Considering 
more than one-third of our patients requiring ra-
bies PEP traveled for <1 month, the vaccine is safe 
and effective,    17     and rabies is a uniformly fatal dis-
ease; we would emphasize the need to consider this 
vaccination in all travelers to endemic areas. 
  Mycobacterium tuberculosis is increasingly rec-
ognized as a common infection acquired in travelers 
going from tuberculosis low-endemicity to high-
  endemicity countries.    18  –  20     The risk of acquisition is 
estimated to be the same as that of the general popu-
lation of the countries to which they have traveled.   18,21     
Although tuberculosis was the seventh most com-
mon diagnosis in travelers in our study, it was signiﬁ  -
cantly more common in visitors to Australia (OR 7.9) 
than in Australian residents traveling overseas. In 
fact, travelers who were not visitors or expatriates 
were signiﬁ  cantly less likely to present with tubercu-
losis than other diagnoses (OR 0.1), despite this pop-
ulation representing 26% of cases in travelers. Thus, 
                Table     4         Comparison between travelers and immigrants/refugees         
         Travelers (917)   Immigrants/refugees (189)   Signiﬁ  cance*         
  Inpatient   472 (52%)    36 (19%)    4.5, (3.0  –  6.7),   p   < 0.0001     
  Demographics        
       Mean age    33.9 yr    35.5 yr    NS     
       Median age    30 yr    32 yr    NS     
       Age range    4  –  98 yr    16  –  84 yr    NS     
       Male   526 (57%)    100 (53%)    NS     
  Diagnoses      †             
       Malaria   174 (19%)    6 (3%)    7.1 (3.0  –  18.2),   p   < 0.0001     
       Gastroenteritis   136 (15%)    4 (2%)    8.1, (2.8  –  25.9),   p   < 0.0001     
       URTI   61 (7%)    4 (2%)      3.3  , (1.1  –  10.8),   p     =   0.02     
       Illness unknown    53 (6%)    1 (<1%)      11.5  , (1.7  –  226),   p   < 0.01     
       Tuberculosis   42 (5%)    94 (50%)      0.05  , (0.0  –  0.1),   p   < 0.0001     
       Schistosomiasis   35 (4%)    24 (12%)      0.3  , (0.2  –  0.5),   p   < 0.0001     
       Helminth   30 (3%)    18 (9%)      0.3  , (0.2  –  0.6),   p   < 0.001     
       Pneumonia   29 (3%)    1 (<1%)      6.1  , (0.9  –  122),   p     =   0.04     
       Chronic hepatitis    3 (<1%)    17 (9%)      0.04  , (0.0  –  0.2),   p   < 0.0001     
       Leprosy   2 (<1%)    12 (6%)      0.03  , (0.0  –  0.2),   p   < 0.0001     
    Clinical and laboratory          
       Fever   589 (64%)    35 (18%)      7.9  , (5.3  –  11.9),   p   < 0.0001     
       Gastrointestinal symptoms    392 (43%)    27 (14%)      4.5  , (2.9  –  7.0),   p   < 0.0001     
       Respiratory symptoms    180 (20%)    30 (16%)    NS     
       Skin symptoms    344 (38%)    18 (10%)      5.7  , (3.4  –  9.8),   p   < 0.0001     
       Neurological symptoms    333 (36%)    12 (6%)      4.5  , (4.5  –  16.1),   p   < 0.0001     
       Asymptomatic   61 (7%)    69 (37%)      0.1  , (0.1  –  0.2),   p   < 0.0001     
       Splenomegaly   39 (4%)    7 (4%)    NS     
       Hepatomegaly   36 (4%)    4 (2%)    NS     
       Anemia (HB < 11.0)    50/572 (9%)    13/84 (15%)      0.4  , (0.2  –  0.8),   p   < 0.01     
       Eosinophilia   49/640 (8%)    17/79 (22%)      0.3  , (0.2  –  0.6),   p   < 0.0001     
    Time to presentation          
   <1  mo    479 (73%)    5 (3%)      96  , (38  –  270),   p   < 0.0001     
   1  –  6 mo    148 (23%)    36 (19%)    NS     
   >6  mo    29 (4%)    142 (78%)      0.01  , (0.01  –  0.02),   p   < 0.0001     
    Mode of transmission          
   Vector-borne    250 (33%)    6 (4%)      13.3  , (5.6  –  33.7),   p   < 0.0001     
    Food- and waterborne    213 (28%)    15 (9%)      4.0  , (2.2  –  7.2),   p   < 0.0001     
   Respiratory    156 (20%)    99 (59%)      0.2  , (0.1  –  0.3),   p   < 0.0001     
   Skin    143 (18%)    45 (27%)      0.6  , (0.4  –  0.9),   p   < 0.01     
   Sexual    8 (1%)    4 (2%)    NS     
          *  Figures in bold represent odds ratio, and ﬁ  gures in parentheses represent 95% conﬁ  dence intervals.
                    †     Only diagnoses with signiﬁ  cant differences shown.
NS = Not signiﬁ  cant                 151
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our study conﬁ  rms that tuberculosis occurs in travel-
ers, but it especially needs to be considered in visitors 
from high-endemic countries. 
  Immigrants and refugees who migrate from coun-
tries with high tuberculosis endemicity to those with 
low endemicity have high rates of developing tuber-
culous disease in their adopted country.    22  –  24     Immi-
grants and refugees represented the majority of 
tuberculosis cases in our study being 21 times more 
likely to present with tuberculosis than travelers. 
  Six percent of travelers (53/917) developed a 
potentially vaccine-preventable disease (inﬂ  uenza, 
23 cases; typhoid fever, 20 cases; hepatitis A, 10 
cases; measles, 1 case), and in 15 of 48 (31%) cases, 
where the information was known, the vaccine had 
not been administered despite pretravel medical 
consultation. Furthermore, those who had been 
vaccinated for typhoid fever and hepatitis A were 
signiﬁ  cantly less likely to be diagnosed with these 
respective conditions as compared to other diagno-
ses. This reemphasizes the need to consider these 
diagnoses in returned travelers, especially if they 
have not been vaccinated, and also to remind practi-
tioners of the need to consider pretravel vaccination 
for travel to highly endemic areas. 
  Finally, we acknowledge that our study describes 
only the spectrum of illness in returned travelers and 
immigrants/refugees seen by specialist infectious 
diseases units in large teaching hospitals. This re-
sults in a referral bias where the more severe and ex-
otic infections are more likely to be seen. In addition, 
as the study involves travelers and immigrants/refu-
gees presenting in Australia, the type of diagnoses 
reﬂ  ects the travel or immigration patterns of those 
entering Australia. In our population of travelers, 
70% had returned from the local region (Asia and 
the Paciﬁ  c) and only 15% from Africa and 2% from 
Latin America. This differs from studies performed 
in Europe or North America    4,5,11,25     where increased 
proportions travel to Africa and Latin America.  
    Conclusions 
  We have described the spectrum of illness, epidemi-
ology, clinical features, and modes of transmission 
of overseas acquired illness in returned travelers and 
immigrants/refugees presenting to two hospital-
based Australian infectious diseases units. We have 
found that important differences exist between 
travelers and immigrants/refugees and that travel 
                Table     5         Comparison of travel destination and classiﬁ  cation of traveler for speciﬁ  c diagnoses in travelers  *           
         Asia   Africa   Oceania   LA   ME   Visitor   Expatriate 
  Australian 
traveler         
  Dengue   5.1, 2.2  –  12.7, 
 <0.0001 
  0.1, 0.0  –  0.7, 
 <0.0001 
  NS   NS       †       NS   NS   2.6, 1.1  – 
 6.4,  0.02     
  Malaria   0.4, 0.3  –  0.5, 
 <0.0001 
  2.4, 1.5  –  3.6, 
 <0.0001 
  4.6, 3.0  –  7.0, 
 <0.0001 
  NS   0.1, 0.0  –  0.8, 
 <0.01 
  NS   3.9, 2.5  –  6.0, 
 <0.0001 
  0.5, 0.4  –  0.7, 
 <0.001     
  Schistosomiasis   0.1, 0.0  –  0.3, 
 <0.0001 
  9.0, 4.3  –  19.1, 
 <0.0001 
  NS   NS   NS   0.1, 0.0  – 
 0.98,  0.03 
  NS   NS     
  URTI   NS   NS   NS   NS   NS   0.3, 0.1  – 
 0.98,  0.03 
  NS   3.3, 1.4  – 
 8.1,  0.002     
  Typhoid/
   Paratyphoid 
fever 
  3.0, 1.1  – 
 8.2,  0.02 
  NS   NS       †       NS   2.9, 1.2  – 
 6.8,  <0.01 
  NS   NS     
  Pneumonia   NS   NS   NS       †           †       NS   NS   11.0, 
4.2  –  30.4, 
 <0.0001     
  Tuberculosis   7.9, 2.7  –  26.4, 
 <0.0001 
  NS   NS       †           †       13.6, 6.6  –  28.5, 
 <0.0001 
  NS   0.1, 0.1  –  0.3, 
 <0.0001     
  Rickettsial 
 disease 
  0.2, 0.1  –  0.7, 
 <0.01 
  4.9, 1.7  –  13.8, 
 <0.001 
  NS       †       NS   NS   NS   NS     
  Gastroenteritis/
 diarrhea 
  NS   0.4, 0.2  – 
 0.8,  <0.01 
  NS   2.4, 1.2  –  4.7, 
 <0.01 
  NS   NS   NS   NS     
  Rabies PEP    42, 16  –  116, 
 <0.0001 
  NS   NS   NS   NS   NS   NS   NS     
  Acute hepatitis    NS     †     NS       †       NS   NS       †       12.9, 3.5  –  57, 
 <0.0001     
  Helminthic 
 infection 
  NS   NS   NS   NS   6.9, 2.3  –  19.5, 
 <0.0001 
  NS   NS   NS     
    Entamoeba 
 histolytica   
  NS   NS   NS   NS   NS   NS   4.1, 1.4  –  11.2, 
 0.002 
  NS     
        LA   =   Latin America; ME   =   Middle-East; NS = not signiﬁ  cant           
*  Figures represent odds ratio (OR), 95% conﬁ  dence intervals, and   p   values respectively. OR compares the likelihood of a patient with a certain 
  characteristic (eg, travel to Asia) having a particular diagnosis (eg, dengue fever) by comparing them against the rest of the travelers in the dataset.                   
†     No cases found.                 152
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destination and classiﬁ  cation of traveler can inﬂ  u-
ence the likelihood of speciﬁ  c diagnoses. These 
ﬁ  ndings present important diagnostic clues for the 
clinical assessment of this patient population.      
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